1. Home
  2. GIS vs SCLXW Comparison

GIS vs SCLXW Comparison

Compare GIS & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GIS

General Mills Inc.

N/A

Current Price

$44.58

Market Cap

24.9B

ML Signal

N/A

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIS
SCLXW
Founded
1866
N/A
Country
United States
United States
Employees
N/A
30
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.9B
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GIS
SCLXW
Price
$44.58
$0.15
Analyst Decision
Hold
Analyst Count
15
0
Target Price
$53.27
N/A
AVG Volume (30 Days)
7.9M
4.0K
Earning Date
12-17-2025
03-07-2025
Dividend Yield
5.48%
N/A
EPS Growth
0.65
N/A
EPS
4.63
N/A
Revenue
$18,776,700,000.00
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.61
N/A
Revenue Growth
N/A
22.02
52 Week Low
$42.79
$0.18
52 Week High
$67.35
$0.18

Technical Indicators

Market Signals
Indicator
GIS
SCLXW
Relative Strength Index (RSI) 45.77 49.56
Support Level $43.43 $0.10
Resistance Level $44.78 $0.18
Average True Range (ATR) 1.01 0.03
MACD 0.04 0.01
Stochastic Oscillator 63.56 77.74

Price Performance

Historical Comparison
GIS
SCLXW

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: